We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $692M invested in Intra-Cellular Therapies Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
72% more call options, than puts
Call options by funds: $35.4M | Put options by funds: $20.5M
16% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 44
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0% more funds holding
Funds holding: 131 → 131 (0)
17% less capital invested
Capital invested by funds: $829M → $692M (-$137M)
Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
51
Reduced
44
Closed
13
Calls
$35.4M
Puts
$20.5M
Net Calls
+$14.8M
Net Calls Change
+$5M
Top Buyers
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$24.2M |
| 2 |
Millennium Management
New York
|
+$7.65M |
| 3 |
SC
Samlyn Capital
New York
|
+$6.82M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.39M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.25M |
Top Sellers
| 1 |
PC
PointState Capital
New York
|
-$28.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.14M |
| 3 |
Renaissance Technologies
New York
|
-$4.46M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.81M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$2.78M |
